Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksX Ie Gold Etc Regulatory News (XGDU)

Share Price Information for X Ie Gold Etc (XGDU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.5875
Bid: 35.885
Ask: 35.925
Change: 0.00 (0.00%)
Spread: 0.04 (0.111%)
Open: 35.5875
High: 0.00
Low: 0.00
Prev. Close: 35.5875
XGDU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fee Reduction

24 Aug 2021 07:00

RNS Number : 4638J
Xtrackers ETC PLC
24 August 2021
 

 

Xtrackers ETC plc

a public company limited by shares incorporated under the

laws of Ireland with registered number 627079, having its registered address at Fourth Floor, 3 George's Dock, IFSC, Dublin 1, Ireland

(the "Issuer")

 

IMPORTANT NOTICE TO SECURITYHOLDERS

 of the following Securities issued under the Secured Xtrackers ETC Precious Metal Linked Securities Programme in relation to Series 5 up to 100,000,000,000 Xtrackers IE Physical Gold EUR Hedged ETC Securities (ISIN: DE000A2T5DZ1) ("Series 5") and Series 6 up to 100,000,000,000 Xtrackers IE Physical Gold GBP Hedged ETC Securities (ISIN: DE000A2UDH48) ("Series 6")

(each a "Series" and the "Securities")

 

24 August 2021

 

Dear Securityholder,

 

We hereby refer to the Securities issued by the Issuer and the related Final Terms.

 

Capitalised terms used herein but not otherwise shall have the meanings ascribed to them in the Master Terms and Conditions of the Securities (the "Terms and Conditions") as set out in the Base Prospectus of the Issuer dated 11 March 2021.

 

Further to Conditions 4 and 17 of the Terms and Conditions, we hereby inform you that the following fees in relation to each Series will be reduced as shown below as of 01 September 2021.

 

Series

Base Fee Percentage*

Old FX Hedging Fee Percentage

Old

Product Fee Percentage

Base Fee Percentage*

New FX Hedging Fee Percentage

New Product Fee Percentage

Series 5

15 bps

18 bps

33 bps

15 bps

13 bps

28 bps

Series 6

15 bps

18 bps

33 bps

15 bps

13 bps

28 bps

 

*For the avoidance of doubt, the Base Fee Percentage of each Series remains unchanged.

 

If you are not the ultimate beneficial holder in respect of the Securities, or if you have recently disposed of the Securities, please forward this notice to the ultimate beneficial holder or purchaser respectively.

 

Securityholders with queries relating to this notice may address them to the following email: Xtrackers@dws.com.

 

 

 

Xtrackers ETC plc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUOAKRAVUWURR
Date   Source Headline
12th Jun 20241:09 pmRNSPublication of Final Terms
12th Jun 20241:08 pmRNSPublication of Final Terms
7th Jun 202410:18 amRNSPublication of Final Terms
6th Jun 202410:27 amRNSPublication of Final Terms
4th Jun 202412:54 pmRNSPublication of Final Terms
28th May 202411:16 amRNSPublication of Final Terms
28th May 202411:16 amRNSPublication of Final Terms
24th May 202410:18 amRNSPublication of Final Terms
22nd May 202411:16 amRNSPublication of Final Terms
17th May 20241:56 pmRNSUnaudited Annual Financial Report
16th May 202410:23 amRNSPublication of Final Terms
16th May 202410:19 amRNSPublication of Final Terms
14th May 202411:52 amRNSPublication of Final Terms
14th May 202411:51 amRNSPublication of Final Terms
9th May 202411:49 amRNSPublication of Final Terms
9th May 202411:49 amRNSPublication of Final Terms
8th May 20241:24 pmRNSPublication of Final Terms
3rd May 202412:02 pmRNSPublication of Final Terms
30th Apr 20249:56 amRNSPublication of Final Terms
24th Apr 202410:51 amRNSPublication of Final Terms
24th Apr 202410:49 amRNSPublication of Final Terms
24th Apr 202410:48 amRNSPublication of Final Terms
19th Apr 202410:53 amRNSPublication of Final Terms
17th Apr 202412:24 pmRNSPublication of Final Terms
5th Apr 202410:44 amRNSPublication of Final Terms
2nd Apr 202410:50 amRNSPublication of Final Terms
28th Mar 202410:17 amRNSPublication of Final Terms
28th Mar 202410:16 amRNSPublication of Final Terms
27th Mar 202411:08 amRNSPublication of Final Terms
22nd Mar 202411:55 amRNSPublication of Final Terms
21st Mar 202410:55 amRNSPublication of Final Terms
19th Mar 202410:28 amRNSPublication of Final Terms
15th Mar 20241:53 pmRNSPublication of Final Terms
12th Mar 202410:26 amRNSPublication of Final Terms
8th Mar 202411:00 amRNSPublication of Final Terms
7th Mar 202410:24 amRNSPublication of Final Terms
6th Mar 202411:10 amRNSPublication of Final Terms
4th Mar 20241:42 pmRNSPublication of Final Terms
1st Mar 202411:43 amRNSPublication of Final Terms
1st Mar 202411:41 amRNSPublication of Final Terms
29th Feb 20241:14 pmRNSPublication of Final Terms
28th Feb 202412:07 pmRNSPublication of Final Terms
27th Feb 202412:40 pmRNSNOTICE TO SECURITYHOLDERS - Fee Reduction
26th Feb 20243:20 pmRNSShareholder Notice - Xtrackers ETC
26th Feb 202410:15 amRNSPublication of Final Terms
21st Feb 202410:46 amRNSPublication of Final Terms
13th Feb 20249:37 amRNSPublication of Final Terms
9th Feb 202410:22 amRNSPublication of Final Terms
7th Feb 202412:10 pmRNSPublication of Final Terms
6th Feb 202411:36 amRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.